Literature DB >> 2433383

Antigenic specificity of human antibody to chlamydia in trachoma and lymphogranuloma venereum.

M E Ward, J D Treharne, A Murray.   

Abstract

An understanding of the molecular basis of the humoral immune response to chlamydial infections in man requires the identification of target antigens to which antibodies are directed. The antigenic specificity of antibody from patients with lymphogranuloma venereum (LGV) or trachoma was therefore assessed by Western blotting. Surface polypeptides were first identified using purified chlamydial outer membrane complex as antigen. Antibodies in sera from patients with LGV but not from control negative sera reacted with a wide range of chlamydial surface polypeptides with molecular masses of 19, 29, 41, 58, 63 and 65 kDa. The major component of the antibody response detected by both immunoblotting and immunoprecipitation assay was directed against the major outer membrane protein (MOMP). Antibody to MOMP was species-specific on Western blotting, whereas antibody to several other polypeptides recognized common immunodeterminants on polypeptides of C. psittaci Cal-10 of equivalent molecular mass. Immunologically C. psittaci Cal-10 was more closely related to LGV strains of C. trachomatis than a guinea pig inclusion conjunctivitis strain of C. psittaci. Trachoma sera collected from a village in southern Iran showed predominantly type-specific antibody on micro-immunofluorescence to serotype A or B trachoma agents. These sera showed a weak immune response to MOMP, a pronounced response to a polypeptide of 36 kDa and much less widespread reactivity with other chlamydial polypeptides. The lack of an immune response to SDS-stable immunodeterminants on MOMP might contribute to the susceptibility of trachoma patients to repeated cycles of ocular infection with chlamydiae.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2433383     DOI: 10.1099/00221287-132-6-1599

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  5 in total

1.  Antichlamydial specificity of conjunctival lymphocytes during experimental ocular infection.

Authors:  J A Whittum-Hudson; H R Taylor
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

2.  Monoclonal antibody neutralization of unmanipulated Chlamydia trachomatis serovar A infection of human epithelioid cells (A-431).

Authors:  I S Barsoum; T A Goodman; L K Hardin; D G Colley
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

3.  Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen.

Authors:  Deborah D Crane; John H Carlson; Elizabeth R Fischer; Patrik Bavoil; Ru-ching Hsia; Chun Tan; Cho-chou Kuo; Harlan D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

4.  Identification of T-cell stimulatory antigens of Chlamydia trachomatis using synovial fluid-derived T-cell clones.

Authors:  A B Hassell; D J Reynolds; M Deacon; J S Gaston; J H Pearce
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

5.  Novel Chlamydia trachomatis strains in heterosexual sex partners, Indianapolis, Indiana, USA.

Authors:  Byron E Batteiger; Raymond Wan; James A Williams; Linda He; Arissa Ma; J Dennis Fortenberry; Deborah Dean
Journal:  Emerg Infect Dis       Date:  2014-11       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.